Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

Margie H Danchin, Carl D Kirkwood, Katherine J Lee, Ruth F Bishop, Emma Watts, Frances A Justice, Vanessa Clifford, Donna Cowley, James Peter Buttery, Julie E Bines

Research output: Contribution to journalArticleResearchpeer-review

27 Citations (Scopus)


RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.
Original languageEnglish
Pages (from-to)2610 - 2616
Number of pages7
Issue number23
Publication statusPublished - 2013

Cite this